Literature DB >> 1869869

Subjective experiences related to alcohol use among schizophrenics.

D L Noordsy1, R E Drake, G B Teague, F C Osher, S C Hurlbut, M S Beaudett, T S Paskus.   

Abstract

Comorbid alcohol use disorders are common in schizophrenia. Although a variety of explanatory hypotheses involving self-medication have been proposed, few data available regarding schizophrenic patients' subjective experiences while using alcohol. We report interview data from 75 DSM-III-R schizophrenic outpatients regarding their subjective responses to alcohol. Over half of our sample reported that alcohol improved social anxiety, tension, dysphoria, apathy, anhedonia, and sleep difficulties. Other nonpsychotic experiences were frequently improved as well. In contrast, no more than 15% of subjects reported that alcohol relieved any specific psychotic symptom; similar proportions of subjects reported that alcohol aggravated psychotic symptoms. Reporting that alcohol had a positive effect on nonpsychotic experiences was associated with having lifetime alcohol use disorders. Reporting that alcohol relieved psychotic symptoms was associated both with having lifetime alcohol use disorders and with the number of psychotic symptoms reported. We discuss the implications of these findings for understanding alcohol abuse and dependence among schizophrenics.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1869869     DOI: 10.1097/00005053-199107000-00004

Source DB:  PubMed          Journal:  J Nerv Ment Dis        ISSN: 0022-3018            Impact factor:   2.254


  10 in total

1.  A family intervention program for dual disorders.

Authors:  Kim T Mueser; Lindy Fox
Journal:  Community Ment Health J       Date:  2002-06

Review 2.  Treatment of substance use disorders in schizophrenia: a unifying neurobiological mechanism?

Authors:  Robert M Roth; Mary F Brunette; Alan I Green
Journal:  Curr Psychiatry Rep       Date:  2005-08       Impact factor: 5.285

3.  The role of self-help programs in the rehabilitation of persons with severe mental illness and substance use disorders.

Authors:  D L Noordsy; B Schwab; L Fox; R E Drake
Journal:  Community Ment Health J       Date:  1996-02

Review 4.  Antipsychotic medication-induced dysphoria: its meaning, association with typical vs. atypical medications and impact on adherence.

Authors:  Hanjing Emily Wu; Olaoluwa O Okusaga
Journal:  Psychiatr Q       Date:  2015-06

5.  Insomnia, self-medication, and relapse to alcoholism.

Authors:  K J Brower; M S Aldrich; E A Robinson; R A Zucker; J F Greden
Journal:  Am J Psychiatry       Date:  2001-03       Impact factor: 18.112

6.  Substance dependence and remission in schizophrenia: A comparison of schizophrenia and affective disorders.

Authors:  Melanie E Bennett; Alan S Bellack; Clayton H Brown; Carlo DiClemente
Journal:  Addict Behav       Date:  2009-03-27       Impact factor: 3.913

7.  Use of Legal Drugs by Psychiatric Outpatients: Benefits, Costs, and Change.

Authors:  Kate B Carey; Stephen A Maisto; Michael P Carey; Christopher M Gordon; Christopher J Correia
Journal:  Cogn Behav Pract       Date:  1999

8.  Do treatment improvements in PTSD severity affect substance use outcomes? A secondary analysis from a randomized clinical trial in NIDA's Clinical Trials Network.

Authors:  Denise A Hien; Huiping Jiang; Aimee N C Campbell; Mei-Chen Hu; Gloria M Miele; Lisa R Cohen; Gregory S Brigham; Carrie Capstick; Agatha Kulaga; James Robinson; Lourdes Suarez-Morales; Edward V Nunes
Journal:  Am J Psychiatry       Date:  2009-11-16       Impact factor: 18.112

Review 9.  Detection of substance use disorders in severely mentally ill patients.

Authors:  R E Drake; A I Alterman; S R Rosenberg
Journal:  Community Ment Health J       Date:  1993-04

10.  Impact of substance use disorder on presentation and short-term course of schizophrenia.

Authors:  Rudraprosad Chakraborty; Arunima Chatterjee; Suprakash Chaudhury
Journal:  Psychiatry J       Date:  2014-04-02
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.